fda warning letters compounded tirzepatide 2024 2025 π¨ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Beyond the Headlines: FDA Warning
Description
This is the simplest formulation and the closest to pharmaceutical-grade products
Benefits & Uses Tirzepatide is studied for strong metabolic effects because it acts on two receptors at once
Mounjaro was introduced first and is FDA approved to help people with type 2 diabetes manage blood sugar
A thorough assessment with a provider guides the most appropriate choice
See our syringe guide for help choosing the right size
This Mounjaro injection site pros and cons table compares each injection site to help you choose the best place for you: You should rotate injection sites every week
